These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
330 related articles for article (PubMed ID: 22442301)
21. Deletion of thioredoxin-interacting protein improves cardiac inotropic reserve in the streptozotocin-induced diabetic heart. Myers RB; Fomovsky GM; Lee S; Tan M; Wang BF; Patwari P; Yoshioka J Am J Physiol Heart Circ Physiol; 2016 Jun; 310(11):H1748-59. PubMed ID: 27037370 [TBL] [Abstract][Full Text] [Related]
22. Thioredoxin-interacting protein promotes islet amyloid polypeptide expression through miR-124a and FoxA2. Jing G; Westwell-Roper C; Chen J; Xu G; Verchere CB; Shalev A J Biol Chem; 2014 Apr; 289(17):11807-11815. PubMed ID: 24627476 [TBL] [Abstract][Full Text] [Related]
23. Evaluating the antidiabetic effects of R-verapamil in type 1 and type 2 diabetes mellitus mouse models. Chen YS; Weng SJ; Chang SH; Li RY; Shane GT; Hsu JP; Yeh SW; Chang AC; Lee MJ PLoS One; 2021; 16(8):e0255405. PubMed ID: 34358247 [TBL] [Abstract][Full Text] [Related]
24. Intracellular shuttling and mitochondrial function of thioredoxin-interacting protein. Saxena G; Chen J; Shalev A J Biol Chem; 2010 Feb; 285(6):3997-4005. PubMed ID: 19959470 [TBL] [Abstract][Full Text] [Related]
25. MicroRNA-200 is induced by thioredoxin-interacting protein and regulates Zeb1 protein signaling and beta cell apoptosis. Filios SR; Xu G; Chen J; Hong K; Jing G; Shalev A J Biol Chem; 2014 Dec; 289(52):36275-83. PubMed ID: 25391656 [TBL] [Abstract][Full Text] [Related]
26. Dysregulated Txnip-ROS-Wnt axis contributes to the impaired ischemic heart repair in diabetic mice. Shen M; Bai D; Liu B; Lu X; Hou R; Zeng C; Li N; Fu Z; Li C; Tao L; Wang H; Yin T Biochim Biophys Acta Mol Basis Dis; 2018 Dec; 1864(12):3735-3745. PubMed ID: 30261287 [TBL] [Abstract][Full Text] [Related]
27. A critical role for thioredoxin-interacting protein in diabetes-related impairment of angiogenesis. Dunn LL; Simpson PJ; Prosser HC; Lecce L; Yuen GS; Buckle A; Sieveking DP; Vanags LZ; Lim PR; Chow RW; Lam YT; Clayton Z; Bao S; Davies MJ; Stadler N; Celermajer DS; Stocker R; Bursill CA; Cooke JP; Ng MK Diabetes; 2014 Feb; 63(2):675-87. PubMed ID: 24198286 [TBL] [Abstract][Full Text] [Related]
28. Redox homeostasis and cell cycle activation mediate beta-cell mass expansion in aged, diabetes-prone mice under metabolic stress conditions: Role of thioredoxin-interacting protein (TXNIP). Kehm R; Jähnert M; Deubel S; Flore T; König J; Jung T; Stadion M; Jonas W; Schürmann A; Grune T; Höhn A Redox Biol; 2020 Oct; 37():101748. PubMed ID: 33128997 [TBL] [Abstract][Full Text] [Related]
29. Redox regulation by nuclear factor erythroid 2-related factor 2: gatekeeping for the basal and diabetes-induced expression of thioredoxin-interacting protein. He X; Ma Q Mol Pharmacol; 2012 Nov; 82(5):887-97. PubMed ID: 22869588 [TBL] [Abstract][Full Text] [Related]
30. Inhibition of thioredoxin-interacting protein and inflammasome assembly using verapamil mitigates diabetic retinopathy and pancreatic injury. Eissa LD; Ghobashy WA; El-Azab MF Eur J Pharmacol; 2021 Jun; 901():174061. PubMed ID: 33766618 [TBL] [Abstract][Full Text] [Related]
31. Thioredoxin-Interacting Protein Deficiency Protects against Diabetic Nephropathy. Shah A; Xia L; Masson EA; Gui C; Momen A; Shikatani EA; Husain M; Quaggin S; John R; Fantus IG J Am Soc Nephrol; 2015 Dec; 26(12):2963-77. PubMed ID: 25855771 [TBL] [Abstract][Full Text] [Related]
32. AMP-activated protein kinase (AMPK) mediates nutrient regulation of thioredoxin-interacting protein (TXNIP) in pancreatic beta-cells. Shaked M; Ketzinel-Gilad M; Cerasi E; Kaiser N; Leibowitz G PLoS One; 2011; 6(12):e28804. PubMed ID: 22194917 [TBL] [Abstract][Full Text] [Related]
34. Palmitate and insulin counteract glucose-induced thioredoxin interacting protein (TXNIP) expression in insulin secreting cells via distinct mechanisms. Panse M; Kluth O; Lorza-Gil E; Kaiser G; Mühlbauer E; Schürmann A; Häring HU; Ullrich S; Gerst F PLoS One; 2018; 13(5):e0198016. PubMed ID: 29813102 [TBL] [Abstract][Full Text] [Related]
35. mTOR controls ChREBP transcriptional activity and pancreatic β cell survival under diabetic stress. Chau GC; Im DU; Kang TM; Bae JM; Kim W; Pyo S; Moon EY; Um SH J Cell Biol; 2017 Jul; 216(7):2091-2105. PubMed ID: 28606928 [TBL] [Abstract][Full Text] [Related]
36. Inhibition of histone acetyltransferase by naringenin and hesperetin suppresses Txnip expression and protects pancreatic β cells in diabetic mice. Wang SW; Sheng H; Bai YF; Weng YY; Fan XY; Zheng F; Fu JQ; Zhang F Phytomedicine; 2021 Jul; 88():153454. PubMed ID: 33663922 [TBL] [Abstract][Full Text] [Related]
37. [Effect of diabetic induced thioredoxin interacting protein (TXNIP) on islet cell senescence]. Huo HY; Wang J; Zhang XM; Zhang WT; Yue JP; Jiao XY Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2020 Mar; 36(2):119-123. PubMed ID: 32744003 [No Abstract] [Full Text] [Related]
38. A potential mechanism of metformin-mediated regulation of glucose homeostasis: inhibition of Thioredoxin-interacting protein (Txnip) gene expression. Chai TF; Hong SY; He H; Zheng L; Hagen T; Luo Y; Yu FX Cell Signal; 2012 Aug; 24(8):1700-5. PubMed ID: 22561086 [TBL] [Abstract][Full Text] [Related]
39. Diabetes pathogenic mechanisms and potential new therapies based upon a novel target called TXNIP. Thielen L; Shalev A Curr Opin Endocrinol Diabetes Obes; 2018 Apr; 25(2):75-80. PubMed ID: 29356688 [TBL] [Abstract][Full Text] [Related]
40. Overview on Thioredoxin-Interacting Protein (TXNIP): A Potential Target for Diabetes Intervention. Basnet R; Basnet TB; Basnet BB; Khadka S Curr Drug Targets; 2022; 23(7):761-767. PubMed ID: 35240955 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]